Richard Ghalie

Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients

Robert H. Vonderheide, Janice P. Dutcher, Jeanne E. Anderson et al. · Journal of Clinical Oncology · 2001 · 225 citations

Pharmacy, Oncology, Pharmacology +17

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Andres Forero, Paul L. Weiden, Julie M. Vose et al. · Blood · 2004 · 152 citations · Full text

Medicine, Immunology, Oncology +13

Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma

Arnold S. Freedman, Sattva S. Neelapu, Craig R. Nichols et al. · Journal of Clinical Oncology · 2009 · 138 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials

Sergio Giralt, William Bensinger, Mark Goodman et al. · Blood · 2003 · 121 citations · Full text

Medicine, Hematology, Oncology +16

Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes

Guillermo Garcia‐Manero, Guillermo Montalban‐Bravo, Jesús G. Berdeja et al. · Cancer · 2017 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11